Recombinant Stenotrophomonas maltophilia Methylthioribose-1-phosphate isomerase (mtnA)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder. We will ship the format we have in stock. If you have special format requirements, please note them when ordering.
Lead Time
Delivery time varies by purchasing method and location. Consult your local distributor for specific delivery times. All proteins are shipped with normal blue ice packs. Request dry ice in advance for an extra fee.
Notes
Avoid repeated freezing and thawing. Working aliquots are stable at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer ingredients, storage temperature, and protein stability. Liquid form is generally stable for 6 months at -20°C/-80°C. Lyophilized form is generally stable for 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us and we will prioritize its development.
Synonyms
mtnA; Smlt3138; Methylthioribose-1-phosphate isomerase; M1Pi; MTR-1-P isomerase; EC 5.3.1.23; S-methyl-5-thioribose-1-phosphate isomerase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-354
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Stenotrophomonas maltophilia (strain K279a)
Target Names
mtnA
Target Protein Sequence
MNTASDIDYA RYDHIRPILW TGDALQLLDQ RKLPFVVEHV VCHDSDEVAA AIHALTVRGA PAIGIAAAWG VVLAARDVQA ADGAHALQQL EPALQRLNAS RPTAVNLAWA LARMRRCLNA AGADWKAKLE AEAQAIAEED LAANRHMGAL GAGLIEAGSG VLTHCNTGSL ATAGFGTALG VIRAGMAQHR IARVFAGETR PWLQGARLTV WELQQDGIDA TLIADSAASH LMKTGAVQWV IVGADRICAN GDTANKIGTY QLAIAARHHG VKFMVVAPSS TVDMETVDGS QIEIEQRDPG ELYGVGGTRT VAEGIAAWNP VFDVTPGELI DAIVTERGVI LNPTPENMRA AFGG
Uniprot No.

Target Background

Function
Catalyzes the interconversion of methylthioribose-1-phosphate (MTR-1-P) and methylthioribulose-1-phosphate (MTRu-1-P).
Database Links
Protein Families
EIF-2B alpha/beta/delta subunits family, MtnA subfamily

Q&A

What is Stenotrophomonas maltophilia and why is it significant in research?

Stenotrophomonas maltophilia is a multidrug-resistant (MDR) opportunistic pathogen responsible for various nosocomial infections, particularly in highly debilitated patients. It has evolved to become one of the leading multidrug-resistant pathogens worldwide, representing a serious threat to healthcare settings . Its significance in research stems from its remarkable ability to resist most clinically used antimicrobials, including β-lactams, aminoglycosides, and macrolides . The genus Stenotrophomonas has experienced taxonomic challenges with several reclassifications, making it an important subject for genomic studies. Recent research has revealed that clinical isolates previously identified as S. maltophilia actually represent a complex (Smc) containing multiple cryptic genomospecies with high genetic diversity .

What genomic approaches have revealed new insights about S. maltophilia taxonomy?

Genome-based taxonomy approaches have transformed our understanding of the Stenotrophomonas maltophilia complex. Whole genome sequencing of clinical isolates, coupled with phylogenomic analysis comparing type strains, has identified at least five cryptic genomospecies associated with clinical infections that were previously classified simply as S. maltophilia . These genomic approaches have revealed that:

  • Clinical isolates of S. maltophilia share a surprisingly small core genome, indicating high genetic diversity

  • The impact of recombination exceeds mutation in the diversification of clinical S. maltophilia isolates

  • Multiple novel species within the Smc are associated with human infections

These findings highlight the importance of genome-based approaches for accurate bacterial species delineation and may improve clinical diagnostics and understanding of species-specific clinical manifestations .

What are the key considerations for planning experiments with S. maltophilia?

When designing experiments with S. maltophilia, researchers should follow established experimental planning principles to generate reliable data. Three key elements of experimental planning must be reported in the methods section:

  • Blinding procedures: Implementing proper blinding techniques to avoid observer bias

  • Randomization methods: Ensuring appropriate randomization of experimental units

  • Adequate group sizes: Using sufficient sample sizes to achieve statistical power

How should researchers approach recombinant DNA experiments with S. maltophilia?

Researchers working with recombinant S. maltophilia DNA must adhere to the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. Under these guidelines, recombinant DNA molecules are defined as:

  • Molecules constructed outside living cells by joining natural or synthetic DNA segments to DNA molecules that can replicate in a living cell

  • Molecules that result from the replication of those described above

When planning such experiments, researchers should:

  • Review applicable regulatory documents to determine the classification of their work under NIH Guidelines

  • Understand the Principal Investigator's responsibilities under these guidelines

  • Register with the Institutional Biosafety Committee (IBC) if the work is not exempt

  • Ensure all laboratory workers receive appropriate training before beginning new experiments

  • Develop protocols for responding to personnel exposures and biological material spills

What genomic analysis techniques are useful for studying mtnA in the context of S. maltophilia diversity?

To study mtnA within the context of S. maltophilia genomic diversity, researchers should consider:

  • Comparative genomics analysis: Collect genome sequences from multiple S. maltophilia isolates from public databases like NCBI with high average nucleotide identity (ANI) values (>95%) for thorough comparison .

  • Core genome analysis: Employ tools like PanX pipeline (https://pangenome.org/) to identify genes shared across all genomes, construct strain-level phylogeny using single nucleotide polymorphisms (SNPs) in the core genome .

  • Multi-locus sequence typing (MLST): For placement of strains carrying mtnA variants within established sequence types, noting that novel sequence types continue to be identified (e.g., ST925, ST926, and ST928 recently discovered) .

  • Phylogenetic tree construction: Utilize MEGA11 or similar tools for visualizing relationships between strains based on core genome analysis .

This methodological approach provides crucial context for understanding mtnA variation and function across the diverse S. maltophilia complex.

How can researchers effectively characterize recombination events affecting metabolic genes like mtnA?

Recombination analysis has revealed that homologous recombination has a greater impact than mutation in the diversification of clinical S. maltophilia isolates . When studying recombination events affecting metabolic genes like mtnA, researchers should:

  • Extract and align core genomes from multiple S. maltophilia isolates

  • Utilize recombination detection programs to identify recombination breakpoints

  • Calculate the ratio of recombination to mutation events to determine their relative contributions to diversity

  • Map recombination events to specific genomic regions to identify hotspots

This approach can help determine whether metabolic genes like mtnA are subject to horizontal gene transfer or homologous recombination, potentially explaining functional differences observed between strains .

How might protein secretion systems interact with metabolic enzymes like mtnA in S. maltophilia?

S. maltophilia encodes a type IV secretion system (T4SS) that enables contact-dependent killing of heterologous bacteria, including Pseudomonas aeruginosa and Escherichia coli . While the primary role of T4SS appears to be the delivery of antibacterial effectors, the potential interactions between secretion systems and metabolic enzymes like mtnA represent an intriguing research avenue.

Research approaches to investigate these potential interactions could include:

  • Creating knockout mutants of both T4SS components and mtnA to assess reciprocal effects on bacterial fitness

  • Using interbacterial protein translocation assays to determine if metabolic enzymes could be secondary substrates of secretion systems

  • Examining whether environmental conditions that alter methionine metabolism (potentially involving mtnA) affect the expression or function of secretion systems

  • Investigating whether effector proteins delivered by T4SS might influence methionine salvage pathways in recipient bacteria

The techniques used to study effector translocation, such as those applied to demonstrate that RS14245 and RS14255 are bona fide substrates of the T4SS , could be adapted to investigate potential interactions with metabolic pathways.

What bioinformatic approaches can identify potential evolutionary relationships of mtnA across the S. maltophilia complex?

Given the discovery of multiple cryptic genomospecies within the S. maltophilia complex , understanding the evolutionary history of metabolic genes like mtnA requires sophisticated bioinformatic approaches:

  • Whole-genome ANI analysis: Use average nucleotide identity analysis to establish species boundaries within the complex and place mtnA variants in taxonomic context .

  • Core-genome SNP tree construction: Build phylogenetic trees based on SNPs in core genomes using tools like PanX to understand the evolutionary relationships between strains carrying different mtnA variants .

  • Synteny analysis: Examine the genomic context of mtnA across diverse strains to identify conservation or rearrangements in gene neighborhoods.

  • Selection pressure analysis: Calculate dN/dS ratios to determine whether mtnA is under purifying, neutral, or positive selection across different lineages.

  • Homology modeling: Compare predicted protein structures of mtnA variants to identify potentially significant structural differences that might affect function.

These approaches can help determine whether mtnA diversification parallels species boundaries within the complex or follows distinct evolutionary patterns.

What biosafety measures should be implemented when working with recombinant S. maltophilia proteins?

When working with recombinant proteins from multidrug-resistant opportunistic pathogens like S. maltophilia, researchers must implement appropriate biosafety measures:

  • Risk assessment: Evaluate potential hazards associated with the specific S. maltophilia strain and recombinant construct

  • Containment level determination: Based on the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules

  • Exposure response protocols: Develop clear procedures for handling personnel exposures and biological material spills

  • Training requirements: Ensure all laboratory personnel receive appropriate training before beginning work with recombinant materials

Additionally, researchers should be aware of potential toxicity of proteins. For example, some S. maltophilia proteins delivered by the T4SS have been shown to be bactericidal to other organisms, and appropriate safety precautions should be taken even when working with purified recombinant proteins .

How can researchers optimize experimental design when studying antimicrobial resistance mechanisms in S. maltophilia?

S. maltophilia exhibits resistance to multiple antibiotic classes, including β-lactams, aminoglycosides, and macrolides . When designing experiments to study resistance mechanisms and potential metabolic connections:

  • Antibiotic susceptibility testing standardization: Use consistent methodologies across experiments to enable reliable comparisons

  • Control strain selection: Include appropriate reference strains with well-characterized resistance profiles

  • Randomization and blinding: Implement these key experimental design elements to minimize bias

  • Genome-phenotype correlation: Relate resistance phenotypes to specific genetic elements through comparative genomics

  • Adequate group sizes: Determine appropriate sample sizes through power analysis to ensure statistical validity

Researchers should also consider the potential role of metabolic enzymes like mtnA in stress responses or adaptation to antibiotic pressure, designing experiments that can detect indirect effects on resistance mechanisms.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.